{"transactions":[{"id":716279,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TR&DT"}}],"security":"Restricted Stock Units","published_at":"2026-07-06T20:41:42.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":11180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Grant of restricted stock units (\"RSUs\") pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the \"Plan\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All RSUs reported in this row were granted under the Plan and will vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All RSUs reported in this row were granted under the Plan and will vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued service through such date."}],"balance_after":54530,"derivative":{"underlying":"Common Stock","underlying_shares":11180},"source":{"system":"sec-edgar","filing":"0001563606-26-000003","document":"wk-form4_1783370499.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000156360626000003/wk-form4_1783370499.xml","form_type":"4"}},{"id":847151,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Restricted Stock Units","published_at":"2026-03-12T21:17:35.000Z","date":"2026-03-11","kind":"grant","planned":false,"acquired":true,"shares":43350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026."}],"balance_after":43350,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":43350},"source":{"system":"sec-edgar","filing":"0001563606-26-000001","document":"wk-form4_1773350251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000156360626000001/wk-form4_1773350251.xml","form_type":"4"}},{"id":847150,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2026-03-12T21:17:35.000Z","date":"2026-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":8487,"price":9.61,"value":81560.07,"ownership":{"direct":true},"balance_after":66387,"source":{"system":"sec-edgar","filing":"0001563606-26-000001","document":"wk-form4_1773350251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000156360626000001/wk-form4_1773350251.xml","form_type":"4"}},{"id":847149,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2026-03-12T21:17:35.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":687,"price":9.55,"value":6560.85,"ownership":{"direct":true},"balance_after":74874,"source":{"system":"sec-edgar","filing":"0001563606-26-000001","document":"wk-form4_1773350251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000156360626000001/wk-form4_1773350251.xml","form_type":"4"}},{"id":1208385,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Non- Qualified Stock Option (right to buy)","published_at":"2025-03-13T20:25:49.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":26310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2025."}],"balance_after":26310,"derivative":{"exercise_price":23.95,"expiration_date":"2033-03-11","underlying":"Non-Qualified Stock Option  (right to buy)","underlying_shares":26310},"source":{"system":"sec-edgar","filing":"0000917520-25-000024","document":"wk-form4_1741897543.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752025000024/wk-form4_1741897543.xml","form_type":"4"}},{"id":1208384,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2025-03-13T20:25:49.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":12425,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75561,"source":{"system":"sec-edgar","filing":"0000917520-25-000024","document":"wk-form4_1741897543.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752025000024/wk-form4_1741897543.xml","form_type":"4"}},{"id":1208383,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2025-03-13T20:25:49.000Z","date":"2025-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":907,"price":23.95,"value":21722.65,"ownership":{"direct":true},"balance_after":63136,"source":{"system":"sec-edgar","filing":"0000917520-25-000024","document":"wk-form4_1741897543.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752025000024/wk-form4_1741897543.xml","form_type":"4"}},{"id":1208382,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2025-03-13T20:25:49.000Z","date":"2025-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":472,"price":23.95,"value":11304.4,"ownership":{"direct":true},"balance_after":64043,"source":{"system":"sec-edgar","filing":"0000917520-25-000024","document":"wk-form4_1741897543.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752025000024/wk-form4_1741897543.xml","form_type":"4"}},{"id":1213464,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2025-03-11T20:17:33.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":592,"price":22.61,"value":13385.12,"ownership":{"direct":true},"balance_after":64515,"source":{"system":"sec-edgar","filing":"0000917520-25-000019","document":"wk-form4_1741724247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752025000019/wk-form4_1741724247.xml","form_type":"4"}},{"id":1579429,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Non- Qualified Stock Option (right to buy)","published_at":"2024-03-13T20:29:52.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":14963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2024."}],"balance_after":14963,"derivative":{"exercise_price":36.22,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":14963},"source":{"system":"sec-edgar","filing":"0000917520-24-000036","document":"wk-form4_1710361779.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000036/wk-form4_1710361779.xml","form_type":"4"}},{"id":1579428,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2024-03-13T20:29:52.000Z","date":"2024-03-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1581,"price":35.88,"value":56726.28,"ownership":{"direct":true},"balance_after":65107,"source":{"system":"sec-edgar","filing":"0000917520-24-000036","document":"wk-form4_1710361779.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000036/wk-form4_1710361779.xml","form_type":"4"}},{"id":1579427,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2024-03-13T20:29:52.000Z","date":"2024-03-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":443,"price":35.88,"value":15894.84,"ownership":{"direct":true},"balance_after":66688,"source":{"system":"sec-edgar","filing":"0000917520-24-000036","document":"wk-form4_1710361779.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000036/wk-form4_1710361779.xml","form_type":"4"}},{"id":1579426,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2024-03-13T20:29:52.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":13805,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":67131,"source":{"system":"sec-edgar","filing":"0000917520-24-000036","document":"wk-form4_1710361779.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000036/wk-form4_1710361779.xml","form_type":"4"}},{"id":1579425,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2024-03-13T20:29:52.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":6478,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":53326,"source":{"system":"sec-edgar","filing":"0000917520-24-000036","document":"wk-form4_1710361779.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000036/wk-form4_1710361779.xml","form_type":"4"}},{"id":1579424,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2024-03-13T20:29:52.000Z","date":"2024-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1952,"price":36.22,"value":70701.44,"ownership":{"direct":true},"balance_after":46848,"source":{"system":"sec-edgar","filing":"0000917520-24-000036","document":"wk-form4_1710361779.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000036/wk-form4_1710361779.xml","form_type":"4"}},{"id":1579423,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2024-03-13T20:29:52.000Z","date":"2024-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":458,"price":36.22,"value":16588.76,"ownership":{"direct":true},"balance_after":48800,"source":{"system":"sec-edgar","filing":"0000917520-24-000036","document":"wk-form4_1710361779.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000036/wk-form4_1710361779.xml","form_type":"4"}},{"id":1582266,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2024-03-12T21:16:37.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":635,"price":36.73,"value":23323.55,"ownership":{"direct":true},"balance_after":49258,"source":{"system":"sec-edgar","filing":"0000917520-24-000029","document":"wk-form4_1710278184.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000029/wk-form4_1710278184.xml","form_type":"4"}},{"id":1587879,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-03-08T21:22:26.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":false,"shares":8736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the stock options vested on the first, second, third and fourth anniversary of the original grant date of March 14, 2016."}],"balance_after":0,"derivative":{"exercise_price":32.585,"expiration_date":"2024-03-14","underlying":"Common Stock","underlying_shares":8736},"source":{"system":"sec-edgar","filing":"0000917520-24-000023","document":"wk-form4_1709932936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000023/wk-form4_1709932936.xml","form_type":"4"}},{"id":1587878,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2024-03-08T21:22:26.000Z","date":"2024-03-06","kind":"sale","planned":false,"acquired":false,"shares":8348,"price":36.5946,"value":305491.7208,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in connection with a broker-assisted \"sell to cover\" cashless exercise transaction to cover the exercise price and withholding taxes upon the exercise of stock options scheduled to expire."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $36.57 to $36.65 The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":49893,"source":{"system":"sec-edgar","filing":"0000917520-24-000023","document":"wk-form4_1709932936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000023/wk-form4_1709932936.xml","form_type":"4"}},{"id":1587877,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2024-03-08T21:22:26.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":true,"shares":8736,"price":32.585,"value":284662.56,"ownership":{"direct":true},"balance_after":58241,"source":{"system":"sec-edgar","filing":"0000917520-24-000023","document":"wk-form4_1709932936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000023/wk-form4_1709932936.xml","form_type":"4"}},{"id":1626579,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2024-02-22T21:43:17.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":3721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 20, 2024, the Compensation Committee certified that the Company met or exceeded the average three-year annual organic revenue growth rate target for the performance period under the March 12, 2021 performance stock award. Accordingly, shares will vest on March 12, 2024, the third anniversary of the grant date."}],"balance_after":49505,"source":{"system":"sec-edgar","filing":"0000917520-24-000004","document":"wk-form4_1708638166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000004/wk-form4_1708638166.xml","form_type":"4"}},{"id":1955271,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-03-14T20:21:08.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":10354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023."}],"balance_after":10354,"derivative":{"exercise_price":52.87,"expiration_date":"2031-03-10","underlying":"Common Stock","underlying_shares":10354},"source":{"system":"sec-edgar","filing":"0001209191-23-018451","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018451/doc4.xml","form_type":"4"}},{"id":1955270,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-03-14T20:21:08.000Z","date":"2023-03-13","kind":"tax_withholding","acquired":false,"shares":1010,"price":52.61,"value":53136.1,"ownership":{"direct":true},"balance_after":45784,"source":{"system":"sec-edgar","filing":"0001209191-23-018451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018451/doc4.xml","form_type":"4"}},{"id":1955269,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-03-14T20:21:08.000Z","date":"2023-03-13","kind":"tax_withholding","acquired":false,"shares":459,"price":52.61,"value":24147.99,"ownership":{"direct":true},"balance_after":46794,"source":{"system":"sec-edgar","filing":"0001209191-23-018451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018451/doc4.xml","form_type":"4"}},{"id":1955268,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-03-14T20:21:08.000Z","date":"2023-03-12","kind":"tax_withholding","acquired":false,"shares":755,"price":52.87,"value":39916.85,"ownership":{"direct":true},"balance_after":47253,"source":{"system":"sec-edgar","filing":"0001209191-23-018451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018451/doc4.xml","form_type":"4"}},{"id":1955267,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-03-14T20:21:08.000Z","date":"2023-03-12","kind":"tax_withholding","acquired":false,"shares":453,"price":52.87,"value":23950.11,"ownership":{"direct":true},"balance_after":48008,"source":{"system":"sec-edgar","filing":"0001209191-23-018451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018451/doc4.xml","form_type":"4"}},{"id":1955266,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-03-14T20:21:08.000Z","date":"2023-03-12","kind":"tax_withholding","acquired":false,"shares":429,"price":52.87,"value":22681.23,"ownership":{"direct":true},"balance_after":48461,"source":{"system":"sec-edgar","filing":"0001209191-23-018451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018451/doc4.xml","form_type":"4"}},{"id":1955265,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-03-14T20:21:08.000Z","date":"2023-03-11","kind":"tax_withholding","acquired":false,"shares":799,"price":52.87,"value":42243.13,"ownership":{"direct":true},"balance_after":48890,"source":{"system":"sec-edgar","filing":"0001209191-23-018451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018451/doc4.xml","form_type":"4"}},{"id":1955264,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-03-14T20:21:08.000Z","date":"2023-03-11","kind":"tax_withholding","acquired":false,"shares":458,"price":52.87,"value":24214.46,"ownership":{"direct":true},"balance_after":49689,"source":{"system":"sec-edgar","filing":"0001209191-23-018451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018451/doc4.xml","form_type":"4"}},{"id":1955263,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-03-14T20:21:08.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":4227,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50147,"source":{"system":"sec-edgar","filing":"0001209191-23-018451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123018451/doc4.xml","form_type":"4"}},{"id":1976155,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-03-03T22:20:31.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":1566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the stock options vested every first, second, third and fourth anniversaries of the grant date of 03/23/2015."}],"balance_after":0,"derivative":{"exercise_price":26.865,"expiration_date":"2023-03-23","underlying":"Common Stock","underlying_shares":1566},"source":{"system":"sec-edgar","filing":"0001209191-23-015775","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123015775/doc4.xml","form_type":"4"}},{"id":1976154,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-03-03T22:20:31.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":1566,"price":55.2127,"value":86463.0882,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $55.2118 to $55.22. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":45920,"source":{"system":"sec-edgar","filing":"0001209191-23-015775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123015775/doc4.xml","form_type":"4"}},{"id":1976153,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-03-03T22:20:31.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":1566,"price":26.865,"value":42070.59,"ownership":{"direct":true},"balance_after":47486,"source":{"system":"sec-edgar","filing":"0001209191-23-015775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123015775/doc4.xml","form_type":"4"}},{"id":2014178,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-02-15T21:25:42.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":1883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date."}],"balance_after":45920,"source":{"system":"sec-edgar","filing":"0001209191-23-009734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123009734/doc4.xml","form_type":"4"}},{"id":2014177,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-02-15T21:25:42.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":1779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date."}],"balance_after":44037,"source":{"system":"sec-edgar","filing":"0001209191-23-009734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123009734/doc4.xml","form_type":"4"}},{"id":2014176,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-02-15T21:25:42.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":1067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date."}],"balance_after":42258,"source":{"system":"sec-edgar","filing":"0001209191-23-009734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123009734/doc4.xml","form_type":"4"}},{"id":2014175,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2023-02-15T21:25:42.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":2379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date."}],"balance_after":41191,"source":{"system":"sec-edgar","filing":"0001209191-23-009734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919123009734/doc4.xml","form_type":"4"}},{"id":2334177,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-15T20:44:15.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":9193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022."}],"balance_after":9193,"derivative":{"exercise_price":65.11,"expiration_date":"2030-03-11","underlying":"Common Stock","underlying_shares":9193},"source":{"system":"sec-edgar","filing":"0001209191-22-018844","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018844/doc4.xml","form_type":"4"}},{"id":2334176,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2022-03-15T20:44:15.000Z","date":"2022-03-13","kind":"tax_withholding","acquired":false,"shares":1080,"price":65.11,"value":70318.8,"ownership":{"direct":true},"balance_after":38812,"source":{"system":"sec-edgar","filing":"0001209191-22-018844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018844/doc4.xml","form_type":"4"}},{"id":2334175,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2022-03-15T20:44:15.000Z","date":"2022-03-13","kind":"tax_withholding","acquired":false,"shares":811,"price":65.11,"value":52804.21,"ownership":{"direct":true},"balance_after":39892,"source":{"system":"sec-edgar","filing":"0001209191-22-018844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018844/doc4.xml","form_type":"4"}},{"id":2334174,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2022-03-15T20:44:15.000Z","date":"2022-03-13","kind":"tax_withholding","acquired":false,"shares":297,"price":65.11,"value":19337.67,"ownership":{"direct":true},"balance_after":40703,"source":{"system":"sec-edgar","filing":"0001209191-22-018844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018844/doc4.xml","form_type":"4"}},{"id":2334173,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2022-03-15T20:44:15.000Z","date":"2022-03-13","kind":"tax_withholding","acquired":false,"shares":335,"price":65.11,"value":21811.85,"ownership":{"direct":true},"balance_after":41000,"source":{"system":"sec-edgar","filing":"0001209191-22-018844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018844/doc4.xml","form_type":"4"}},{"id":2334172,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2022-03-15T20:44:15.000Z","date":"2022-03-12","kind":"tax_withholding","acquired":false,"shares":665,"price":65.11,"value":43298.15,"ownership":{"direct":true},"balance_after":41335,"source":{"system":"sec-edgar","filing":"0001209191-22-018844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018844/doc4.xml","form_type":"4"}},{"id":2334171,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2022-03-15T20:44:15.000Z","date":"2022-03-12","kind":"tax_withholding","acquired":false,"shares":1109,"price":65.11,"value":72206.99,"ownership":{"direct":true},"balance_after":42000,"source":{"system":"sec-edgar","filing":"0001209191-22-018844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018844/doc4.xml","form_type":"4"}},{"id":2334170,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2022-03-15T20:44:15.000Z","date":"2022-03-12","kind":"tax_withholding","acquired":false,"shares":277,"price":65.11,"value":18035.47,"ownership":{"direct":true},"balance_after":43109,"source":{"system":"sec-edgar","filing":"0001209191-22-018844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018844/doc4.xml","form_type":"4"}},{"id":2334169,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2022-03-15T20:44:15.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":4608,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43386,"source":{"system":"sec-edgar","filing":"0001209191-22-018844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018844/doc4.xml","form_type":"4"}},{"id":2334168,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2022-03-15T20:44:15.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":3269,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38778,"source":{"system":"sec-edgar","filing":"0001209191-22-018844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122018844/doc4.xml","form_type":"4"}},{"id":2399304,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2022-02-14T21:35:34.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":6466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 12, 2021 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2022 at 200% of target, the first anniversary of the grant date."}],"balance_after":35509,"source":{"system":"sec-edgar","filing":"0001209191-22-009293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122009293/doc4.xml","form_type":"4"}},{"id":2399303,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2022-02-14T21:35:34.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":3936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2020 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2022 at 150% of target, the second anniversary of the grant date."}],"balance_after":29043,"source":{"system":"sec-edgar","filing":"0001209191-22-009293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122009293/doc4.xml","form_type":"4"}},{"id":2399302,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2022-02-14T21:35:34.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":2956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2019 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2022 at 150% of target, the third anniversary of the grant date."}],"balance_after":25107,"source":{"system":"sec-edgar","filing":"0001209191-22-009293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919122009293/doc4.xml","form_type":"4"}},{"id":2787574,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Non-Qualified Stock Option  (right to buy)","published_at":"2021-03-16T20:15:15.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":9232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/12/2021."}],"balance_after":9232,"derivative":{"exercise_price":68.1,"expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":9232},"source":{"system":"sec-edgar","filing":"0001209191-21-020767","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020767/doc4.xml","form_type":"4"}},{"id":2787573,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2021-03-16T20:15:15.000Z","date":"2021-03-13","kind":"tax_withholding","acquired":false,"shares":210,"price":68.1,"value":14301.0,"ownership":{"direct":true},"balance_after":22151,"source":{"system":"sec-edgar","filing":"0001209191-21-020767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020767/doc4.xml","form_type":"4"}},{"id":2787572,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2021-03-16T20:15:15.000Z","date":"2021-03-13","kind":"tax_withholding","acquired":false,"shares":288,"price":68.1,"value":19612.8,"ownership":{"direct":true},"balance_after":22361,"source":{"system":"sec-edgar","filing":"0001209191-21-020767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020767/doc4.xml","form_type":"4"}},{"id":2787571,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2021-03-16T20:15:15.000Z","date":"2021-03-13","kind":"tax_withholding","acquired":false,"shares":208,"price":68.1,"value":14164.8,"ownership":{"direct":true},"balance_after":22649,"source":{"system":"sec-edgar","filing":"0001209191-21-020767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020767/doc4.xml","form_type":"4"}},{"id":2787570,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2021-03-16T20:15:15.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":3063,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22857,"source":{"system":"sec-edgar","filing":"0001209191-21-020767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121020767/doc4.xml","form_type":"4"}},{"id":2830785,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, TT"}}],"security":"Common Stock","published_at":"2021-02-26T21:08:04.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":24941,"price":69.4825,"value":1732963.0325,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price shown above represents the weighted average price of the shares sold. The range of sale prices was $69.01 to $70.99."}],"balance_after":19794,"source":{"system":"sec-edgar","filing":"0001209191-21-014694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919121014694/doc4.xml","form_type":"4"}},{"id":3207041,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-03-17T20:12:12.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":15887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2020."}],"balance_after":15887,"derivative":{"exercise_price":43.39,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":15887},"source":{"system":"sec-edgar","filing":"0001209191-20-019557","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019557/doc4.xml","form_type":"4"}},{"id":3207040,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2020-03-17T20:12:12.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":1121,"price":43.39,"value":48640.19,"ownership":{"direct":true},"balance_after":44735,"source":{"system":"sec-edgar","filing":"0001209191-20-019557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019557/doc4.xml","form_type":"4"}},{"id":3207039,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2020-03-17T20:12:12.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":570,"price":43.39,"value":24732.3,"ownership":{"direct":true},"balance_after":45856,"source":{"system":"sec-edgar","filing":"0001209191-20-019557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019557/doc4.xml","form_type":"4"}},{"id":3207038,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2020-03-17T20:12:12.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":547,"price":43.39,"value":23734.33,"ownership":{"direct":true},"balance_after":46426,"source":{"system":"sec-edgar","filing":"0001209191-20-019557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019557/doc4.xml","form_type":"4"}},{"id":3207037,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2020-03-17T20:12:12.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":3181,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":46973,"source":{"system":"sec-edgar","filing":"0001209191-20-019557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019557/doc4.xml","form_type":"4"}},{"id":3207036,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2020-03-17T20:12:12.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":226,"price":43.39,"value":9806.14,"ownership":{"direct":true},"balance_after":43792,"source":{"system":"sec-edgar","filing":"0001209191-20-019557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019557/doc4.xml","form_type":"4"}},{"id":3207035,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2020-03-17T20:12:12.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":235,"price":43.39,"value":10196.65,"ownership":{"direct":true},"balance_after":44018,"source":{"system":"sec-edgar","filing":"0001209191-20-019557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019557/doc4.xml","form_type":"4"}},{"id":3207034,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2020-03-17T20:12:12.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":300,"price":43.39,"value":13017.0,"ownership":{"direct":true},"balance_after":44253,"source":{"system":"sec-edgar","filing":"0001209191-20-019557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120019557/doc4.xml","form_type":"4"}},{"id":3267982,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2020-02-18T21:55:19.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":1854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2019 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the first anniversary of the grant date."}],"balance_after":44553,"source":{"system":"sec-edgar","filing":"0001209191-20-010223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120010223/doc4.xml","form_type":"4"}},{"id":3267981,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2020-02-18T21:55:19.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":1778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the second anniversary of the grant date."}],"balance_after":42699,"source":{"system":"sec-edgar","filing":"0001209191-20-010223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120010223/doc4.xml","form_type":"4"}},{"id":3267980,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2020-02-18T21:55:19.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":3649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019, at least 9% and up to a maximum of 33% cumulative increase in annual revenue over the 2016 fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 34% of the shares will vest on March 13, 2020 at 150% of target, the third anniversary of the grant date."}],"balance_after":40921,"source":{"system":"sec-edgar","filing":"0001209191-20-010223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919120010223/doc4.xml","form_type":"4"}},{"id":3455528,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-07-26T20:14:36.000Z","date":"2019-07-24","kind":"exercise","acquired":false,"shares":5052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/14/2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"In accordance with the terms of the stock option plan, the exercise price of the\noption and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016."}],"balance_after":8736,"derivative":{"exercise_price":32.585,"expiration_date":"2024-03-14","underlying":"Common Stock","underlying_shares":5052},"source":{"system":"sec-edgar","filing":"0001209191-19-043330","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119043330/doc4.xml","form_type":"4"}},{"id":3455527,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-07-26T20:14:36.000Z","date":"2019-07-24","kind":"exercise","acquired":false,"shares":4698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/23/2015."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This stock option was previously reported as covering 2,710 shares of common stock at an exercise price of $62.10 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016."}],"balance_after":1566,"derivative":{"exercise_price":26.865,"expiration_date":"2023-03-23","underlying":"Common Stock","underlying_shares":4698},"source":{"system":"sec-edgar","filing":"0001209191-19-043330","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119043330/doc4.xml","form_type":"4"}},{"id":3455526,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-07-26T20:14:36.000Z","date":"2019-07-24","kind":"sale","acquired":false,"shares":5052,"price":63,"value":318276.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":37272,"source":{"system":"sec-edgar","filing":"0001209191-19-043330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119043330/doc4.xml","form_type":"4"}},{"id":3455525,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-07-26T20:14:36.000Z","date":"2019-07-24","kind":"exercise","acquired":true,"shares":5052,"price":32.585,"value":164619.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":42324,"source":{"system":"sec-edgar","filing":"0001209191-19-043330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119043330/doc4.xml","form_type":"4"}},{"id":3455524,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-07-26T20:14:36.000Z","date":"2019-07-24","kind":"sale","acquired":false,"shares":4698,"price":63,"value":295974.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":37272,"source":{"system":"sec-edgar","filing":"0001209191-19-043330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119043330/doc4.xml","form_type":"4"}},{"id":3455523,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-07-26T20:14:36.000Z","date":"2019-07-24","kind":"exercise","acquired":true,"shares":4698,"price":26.865,"value":126211.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":41970,"source":{"system":"sec-edgar","filing":"0001209191-19-043330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119043330/doc4.xml","form_type":"4"}},{"id":3455522,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-07-26T20:14:36.000Z","date":"2019-07-24","kind":"sale","acquired":false,"shares":11234,"price":63.135,"value":709258.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person."}],"balance_after":37272,"source":{"system":"sec-edgar","filing":"0001209191-19-043330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119043330/doc4.xml","form_type":"4"}},{"id":3594112,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-03-15T21:20:15.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":10373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2019."}],"balance_after":10373,"derivative":{"exercise_price":55.91,"expiration_date":"2027-03-13","underlying":"Common Stock","underlying_shares":10373},"source":{"system":"sec-edgar","filing":"0001209191-19-019757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019757/doc4.xml","form_type":"4"}},{"id":3594111,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-03-15T21:20:15.000Z","date":"2019-03-14","kind":"tax_withholding","acquired":false,"shares":309,"price":56.14,"value":17347.26,"ownership":{"direct":true},"balance_after":48506,"source":{"system":"sec-edgar","filing":"0001209191-19-019757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019757/doc4.xml","form_type":"4"}},{"id":3594110,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-03-15T21:20:15.000Z","date":"2019-03-14","kind":"tax_withholding","acquired":false,"shares":1155,"price":56.14,"value":64841.7,"ownership":{"direct":true},"balance_after":48815,"source":{"system":"sec-edgar","filing":"0001209191-19-019757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019757/doc4.xml","form_type":"4"}},{"id":3594109,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-03-15T21:20:15.000Z","date":"2019-03-13","kind":"grant","acquired":false,"shares":2318,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49970,"source":{"system":"sec-edgar","filing":"0001209191-19-019757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019757/doc4.xml","form_type":"4"}},{"id":3594108,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-03-15T21:20:15.000Z","date":"2019-03-13","kind":"tax_withholding","acquired":false,"shares":226,"price":55.91,"value":12635.66,"ownership":{"direct":true},"balance_after":47652,"source":{"system":"sec-edgar","filing":"0001209191-19-019757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019757/doc4.xml","form_type":"4"}},{"id":3594107,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-03-15T21:20:15.000Z","date":"2019-03-13","kind":"tax_withholding","acquired":false,"shares":290,"price":55.91,"value":16213.9,"ownership":{"direct":true},"balance_after":47878,"source":{"system":"sec-edgar","filing":"0001209191-19-019757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019757/doc4.xml","form_type":"4"}},{"id":3594106,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-03-15T21:20:15.000Z","date":"2019-03-13","kind":"tax_withholding","acquired":false,"shares":505,"price":55.91,"value":28234.55,"ownership":{"direct":true},"balance_after":48168,"source":{"system":"sec-edgar","filing":"0001209191-19-019757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019757/doc4.xml","form_type":"4"}},{"id":3594105,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-03-15T21:20:15.000Z","date":"2019-03-13","kind":"tax_withholding","acquired":false,"shares":1088,"price":55.91,"value":60830.08,"ownership":{"direct":true},"balance_after":48673,"source":{"system":"sec-edgar","filing":"0001209191-19-019757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119019757/doc4.xml","form_type":"4"}},{"id":3651177,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-02-19T22:05:07.000Z","date":"2019-02-14","kind":"grant","acquired":true,"shares":1641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal  year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date."}],"balance_after":49761,"source":{"system":"sec-edgar","filing":"0001209191-19-011174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119011174/doc4.xml","form_type":"4"}},{"id":3651176,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-02-19T22:05:07.000Z","date":"2019-02-14","kind":"grant","acquired":true,"shares":3541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date."}],"balance_after":48120,"source":{"system":"sec-edgar","filing":"0001209191-19-011174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119011174/doc4.xml","form_type":"4"}},{"id":3651175,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2019-02-19T22:05:07.000Z","date":"2019-02-14","kind":"grant","acquired":true,"shares":3759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date."}],"balance_after":44579,"source":{"system":"sec-edgar","filing":"0001209191-19-011174","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919119011174/doc4.xml","form_type":"4"}},{"id":3982402,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2018-03-27T21:35:34.000Z","date":"2018-03-23","kind":"tax_withholding","acquired":false,"shares":507,"price":54.15,"value":27454.05,"ownership":{"direct":true},"balance_after":40820,"source":{"system":"sec-edgar","filing":"0001209191-18-021799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118021799/doc4.xml","form_type":"4"}},{"id":3982401,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2018-03-27T21:35:34.000Z","date":"2018-03-23","kind":"tax_withholding","acquired":false,"shares":507,"price":54.15,"value":27454.05,"ownership":{"direct":true},"balance_after":41327,"source":{"system":"sec-edgar","filing":"0001209191-18-021799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118021799/doc4.xml","form_type":"4"}},{"id":3995272,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-15T20:21:44.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":8609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2018."}],"balance_after":8609,"derivative":{"exercise_price":56.23,"expiration_date":"2026-03-13","underlying":"Common Stock","underlying_shares":8609},"source":{"system":"sec-edgar","filing":"0001209191-18-019839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118019839/doc4.xml","form_type":"4"}},{"id":3995271,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2018-03-15T20:21:44.000Z","date":"2018-03-14","kind":"tax_withholding","acquired":false,"shares":299,"price":56.14,"value":16785.86,"ownership":{"direct":true},"balance_after":41834,"source":{"system":"sec-edgar","filing":"0001209191-18-019839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118019839/doc4.xml","form_type":"4"}},{"id":3995270,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2018-03-15T20:21:44.000Z","date":"2018-03-14","kind":"tax_withholding","acquired":false,"shares":1120,"price":56.14,"value":62876.8,"ownership":{"direct":true},"balance_after":42133,"source":{"system":"sec-edgar","filing":"0001209191-18-019839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118019839/doc4.xml","form_type":"4"}},{"id":3995269,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2018-03-15T20:21:44.000Z","date":"2018-03-13","kind":"tax_withholding","acquired":false,"shares":290,"price":56.23,"value":16306.7,"ownership":{"direct":true},"balance_after":43253,"source":{"system":"sec-edgar","filing":"0001209191-18-019839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118019839/doc4.xml","form_type":"4"}},{"id":3995268,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2018-03-15T20:21:44.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":2224,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43543,"source":{"system":"sec-edgar","filing":"0001209191-18-019839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118019839/doc4.xml","form_type":"4"}},{"id":3995267,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2018-03-15T20:21:44.000Z","date":"2018-03-13","kind":"tax_withholding","acquired":false,"shares":1088,"price":56.23,"value":61178.24,"ownership":{"direct":true},"balance_after":41319,"source":{"system":"sec-edgar","filing":"0001209191-18-019839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118019839/doc4.xml","form_type":"4"}},{"id":4049180,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2018-02-20T21:27:38.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":3541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date."}],"balance_after":42407,"source":{"system":"sec-edgar","filing":"0001209191-18-011349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118011349/doc4.xml","form_type":"4"}},{"id":4049179,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2018-02-20T21:27:38.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":3645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date."}],"balance_after":38866,"source":{"system":"sec-edgar","filing":"0001209191-18-011349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118011349/doc4.xml","form_type":"4"}},{"id":4049178,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2018-02-20T21:27:38.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":1650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date."}],"balance_after":35221,"source":{"system":"sec-edgar","filing":"0001209191-18-011349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919118011349/doc4.xml","form_type":"4"}},{"id":4371906,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2017-03-27T23:15:14.000Z","date":"2017-03-24","kind":"tax_withholding","acquired":false,"shares":794,"price":42.74,"value":33935.56,"ownership":{"direct":true},"balance_after":33571,"source":{"system":"sec-edgar","filing":"0001209191-17-023008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919117023008/doc4.xml","form_type":"4"}},{"id":4371905,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2017-03-27T23:15:14.000Z","date":"2017-03-24","kind":"tax_withholding","acquired":false,"shares":794,"price":42.74,"value":33935.56,"ownership":{"direct":true},"balance_after":34365,"source":{"system":"sec-edgar","filing":"0001209191-17-023008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919117023008/doc4.xml","form_type":"4"}},{"id":4371904,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2017-03-27T23:15:14.000Z","date":"2017-03-23","kind":"tax_withholding","acquired":false,"shares":541,"price":42.35,"value":22911.35,"ownership":{"direct":true},"balance_after":35159,"source":{"system":"sec-edgar","filing":"0001209191-17-023008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919117023008/doc4.xml","form_type":"4"}},{"id":4371903,"issuer":{"id":2707,"kind":"organization","name":"INTEGRA LIFESCIENCES HOLDINGS CORP","symbol":"IART"},"owners":[{"id":32362,"kind":"person","name":"DAVIS ROBERT T. JR.","position":1,"cik":"0001563606","reported_name":"DAVIS ROBERT T. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CVP,PRES-ORTHO & TISSUE TECH"}}],"security":"Common Stock","published_at":"2017-03-27T23:15:14.000Z","date":"2017-03-23","kind":"tax_withholding","acquired":false,"shares":541,"price":42.35,"value":22911.35,"ownership":{"direct":true},"balance_after":35700,"source":{"system":"sec-edgar","filing":"0001209191-17-023008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/917520/000120919117023008/doc4.xml","form_type":"4"}}],"next_cursor":"2017-03-27T23:15:14.000000Z,4371903"}